fibrinogen has been researched along with Pulmonary Disease, Chronic Obstructive in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 22 (23.91) | 29.6817 |
2010's | 57 (61.96) | 24.3611 |
2020's | 13 (14.13) | 2.80 |
Authors | Studies |
---|---|
Antony, VB; Athar, M; Bae, S; Dransfield, MT; Dsouza, KG; Kim, YI; Li, FJ; Liu, RM; Singh, P; Stephens, CT; Surolia, R; Wang, Z | 1 |
Araújo, AS; Figueiredo, MR; Lomonaco, I; Lundgren, F; Mesquita, R; Pereira, EDB | 1 |
Cao, Z; Luo, Z; Ma, Y; Sun, W; Wang, J; Zhang, L | 1 |
Gong, L; He, D; He, Q; Huang, D; Liang, Z; Shi, Y; Wang, W; Wu, Z; Yang, L; Yao, R; Zhang, Z | 1 |
Badr, MY; Bahey, MG; Elkholy, AA; Mohamed, EA; Reda, AM; Shoeib, SM | 1 |
Hu, X; Li, P; Xu, J; Zheng, H | 1 |
Sin, DD | 1 |
Gao, Y; Han, M; Li, T; Li, X; Liu, Y; Wang, L; Wang, X; Wu, D; Xu, Y; Zhu, Y | 1 |
Gibbons, LP; Holden, NS; Jenkins, AR; Jones, AW | 1 |
Barrecheguren, M; Esquinas, C; Gava, G; Loeb, E; Miravitlles, M; Núñez, A; Pirina, P; Sarasate, M | 1 |
Čepelak, I; Hlapčić, I; Popović-Grle, S; Rako, I; Rogić, D; Rumora, L | 1 |
He, D; Liu, S; Niu, W; Wang, K; Wang, Y; Yang, T; Zhang, Q; Zhang, Z; Zhou, B | 1 |
Holden, NS; Jenkins, AR; Jones, AW | 1 |
Criner, GJ; Dransfield, MT; Halpin, DMG; Han, MK; Lange, P; Lettis, S; Lipson, DA; Lomas, D; Mannino, D; Martin, N; Martinez, FJ; Miller, BE; Singh, D; Wise, R; Zhu, CQ | 1 |
Andrijevic, I; Andrijevic, L; Jokic, D; Milutinov, S; Vukoja, M | 1 |
Adachi, O; Akiyama, M; Hayatsu, Y; Hosoyama, K; Kawamoto, S; Kawatsu, S; Kumagai, K; Masaki, N; Motoyoshi, N; Saiki, Y; Sakatsume, K; Sakuma, K; Sasaki, K; Suzuki, Y; Takahara, S; Yoshioka, I | 1 |
Cheriyan, J; Cockcroft, JR; Fisk, M; Forman, J; Fuld, J; Hopkinson, NS; Lomas, DA; Mäki-Petäjä, KM; McEniery, CM; Mohan, D; Polkey, MI; Rudd, JHF; Tal-Singer, R; Wilkinson, IB | 1 |
Allinder, M; Bolton, CE; Calverley, PMA; Cheriyan, J; Cockcroft, JR; Fisk, M; Forman, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; Marchong, M; McEniery, CM; Miller, BE; Mohan, D; Nagarajan, S; Polkey, MI; Tal-Singer, R; Wilkinson, IB | 1 |
Karsdal, MA; Langholm, LL; Leeming, DJ; Manon-Jensen, T; Miller, BE; Rønnow, SR; Sand, JMB; Tal-Singer, R; Vestbo, J | 1 |
Anderson, JA; Brook, R; Calverley, P; Celli, BR; Cowans, NJ; Crim, C; Dixon, I; Kim, V; Martinez, FJ; Morris, A; Newby, DE; Vestbo, J; Yates, J | 1 |
Hyun, DG; Lee, JS; Lee, SD; Lee, SW; Oh, YM | 1 |
Park, SY; Yoo, KH | 1 |
Cazzola, M; Ora, J; Puxeddu, E; Rogliani, P | 1 |
Ancochea, J; Duran-Tauleria, E; García-Rio, F; Miravitlles, M; Muñoz, L; Sánchez, G; Sobradillo, V; Soriano, JB | 1 |
Akkermans, R; Heijdra, Y; Lenders, JW; Scheepers, PT; Schermer, TR; van Dijk, WD; Weel, Cv | 1 |
Casaburi, R; Celli, B; Crapo, J; Criner, G; Croxton, T; Gaw, A; Jones, P; Kline-Leidy, N; Lomas, DA; Merrill, D; Polkey, M; Rennard, S; Sciurba, F; Stockley, R; Tal-Singer, R; Turino, G; Vestbo, J; Walsh, J | 1 |
Dahl, M; Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
Mador, MJ; Sethi, S | 1 |
Cao, ZG; Li, JY; Li, Y; Wang, RT | 1 |
Albarrán Lozano, I; Alonso González, P; Comeche Casanova, L; Echave-Sustaeta, JM; García Luján, R; Llorente Alonso, MJ | 1 |
Donaldson, GC; Garcha, DS; George, SN; Hurst, JR; Kowlessar, BS; Mackay, AJ; Patel, AR; Singh, R; Wedzicha, JA | 1 |
Centanni, S; Di Marco, F; Pellegrino, GM; Pontiroli, AE; Repossi, AC; Roggi, MA; Santus, P; Terraneo, S; Veronelli, A | 1 |
Agusti, A; Sin, DD | 1 |
Agustí, À; Antó, JM; Basagaña, X; Beelen, R; Benet, M; Cirach, M; Dadvand, P; de Batlle, J; Ferrer, A; Ferrer, J; Garcia-Aymerich, J; Guerra, S; Hoek, G; Martinez, D; Nieuwenhuijsen, MJ; Rodriguez-Roisin, R; Sauleda, J | 1 |
Bolton, CE; Calverley, PM; Cockcroft, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; McEniery, CM; Miller, BE; Mohan, D; Polkey, MI; Shale, DJ; Tal-Singer, R; Wilkinson, IB | 1 |
Crişan, A; Crişan, AF; Fira-Mladinescu, O; Oancea, C; Timar, B; Tudorache, V | 1 |
Coxson, HO; Diaz, AA; Harmouche, R; Hokanson, JE; Kinney, GL; MacNee, W; Maltais, F; McDonald, ML; Rennard, S; Ross, JC; San Jose Estepar, R; Washko, GR; Wouters, EF; Young, TP; Zhou, L | 1 |
Lock-Johansson, S; Sorensen, GL; Vestbo, J | 1 |
Altintas, N; Cinarka, H; Gumus, A; Hazıroglu, M; Karatas, M; Kirbas, A; Sahin, U | 1 |
Cunningham, TJ; Ford, ES; Mannino, DM | 1 |
Chen, Y; Ji, HY; Li, CY; Ren, W; Wang, S; Zhou, Q; Zhu, CD | 1 |
Ingebrigtsen, TS; Lange, P; Marott, JL; Nordestgaard, BG; Rode, L; Vestbo, J | 1 |
Amore, C; Beume, R; Dell'Elba, G; Di Santo, A; Evangelista, V; Martelli, N; Piccoli, A; Tenor, H; Totani, L | 1 |
Furtwaengler, A; Leidy, N; Lowings, M; Mannino, DM; Martin, TR; Martin, UJ; Merrill, DD; Miller, BE; Rennard, SI; Snyder, J; Tal-Singer, R; Walsh, J | 1 |
Hanania, NA; Lavoie, K; Müllerová, H; Rennard, SI; Tal-Singer, R; Vestbo, J; Wouters, EF; Yohannes, AM | 1 |
Hurst, JR | 1 |
Kleniewska, A; Nowakowska-Świrta, E; Piotrowski, W; Walusiak-Skorupa, J; Wiszniewska, M | 1 |
Cantor, JO; Lin, YY; Ma, S; Turino, GM | 1 |
Agusti, A; Halpin, D; Martinez, FJ; Roche, N; Singh, D; Wedzicha, JA | 1 |
Barr, RG; Burke, GL; Cushman, M; Enright, PL; Jiang, R; Kronmal, RA; Margolis, HG; Newman, AB; Tracy, RP; Wang, Y | 1 |
Burghuber, OC; Cekici, L; Eickhoff, P; Geyer, K; Kiss, D; Kohansal, R; Schreder, M; Valipour, A | 1 |
Daniil, ZD; Germenis, A; Gourgoulianis, KI; Kiropoulos, TS; Kostikas, K; Koutsokera, A; Nikoulis, DJ; Papaioannou, AI; Tanou, K; Tsolaki, V | 1 |
Dentener, MA; Houwing-Duistermaat, JJ; Kotz, D; Passos, VL; Spruit, MA; Wouters, EF; Yanbaeva, DG | 1 |
Alexeeff, SE; Litonjua, AA; Mittleman, MA; Poon, A; Schwartz, J; Sparrow, D; Vokonas, PS; Wilker, EH | 1 |
Dahl, M; Nordestgaard, BG | 1 |
Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H | 1 |
Chen, C; Ding, J; Jiang, G; Xu, Z; Zhang, Y; Zhu, Y | 1 |
Casadio, C; Massera, F; Mineo, TC; Papalia, E; Pirondini, E; Rena, O; Turello, D | 1 |
Antoniu, SA | 1 |
Celenk, MK; Geyik, B; Maden, O; Selcuk, H; Selcuk, MT; Tüfekcioglu, O | 1 |
Sata, M | 1 |
Gao, S; Liu, Y; Ning, Q; Wang, X; Xiao, F; Xiong, Y; Xu, S; Yan, W | 1 |
del Puerto-Nevado, L; Girón-Martínez, A; Peces-Barba, G; Pérez-Rial, S | 1 |
Barnacle, H; Barnes, NC; Keene, O; Lipson, DA; Lomas, DA; Miller, BE; Tal-Singer, R; Willits, L | 1 |
Mannino, DM; Müllerova, H; Tal-Singer, R; Valvi, D | 2 |
Carter, RI; Mumford, RA; Stockley, RA; Ungurs, MJ | 1 |
Díaz, PO; Dreyse, DJ; Gaggero, BA; Lisboa, BC; Saldías, PF; Sandoval, AC | 1 |
Agustí, A; Bakke, P; Calverley, PM; Celli, B; Coxson, HO; Crim, C; Edwards, LD; Lomas, DA; MacNee, W; Mayer, RJ; Miller, BE; Rennard, SI; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC | 1 |
Bitter, H; Cheng, DT; Cockayne, DA; Fine, JS; Hilton, H; Holz, O; Kourteva, G; Magnussen, H; Müller, KC; Pillai, SG; Ravindran, P; Sridhar, S; Visvanathan, S; Waschki, B; Watz, H | 1 |
Breyer, MK; Locantore, NW; Miller, BE; Rutten, EP; Watkins, ML; Wouters, EF | 1 |
Cavalcante, AG; Cavalcante, MM; de Bruin, PF; de Bruin, VM; Nunes, DM; Pereira, ED; Viana, CS | 1 |
Dickens, J; Duvoix, A; Haq, I; Lomas, DA; Mannino, D; Miller, B; Tal-Singer, R | 1 |
Lazovic, B | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Thomsen, M; Vestbo, J | 1 |
Akkermans, R; Heijdra, Y; Klerx, W; Lenders, JW; Scheepers, PT; Schermer, TR; van der Pouw, A; van Dijk, WD; van Weel, C | 1 |
MacNee, W | 1 |
Agustí, A; Bakke, P; Beaty, TH; Celli, B; Cho, MH; Coxson, H; Crapo, JD; Gulsvik, A; Hersh, CP; Kim, DK; Kong, X; Litonjua, A; Lomas, DA; MacNee, W; Miller, BE; Qiu, W; Rennard, S; Riley, JH; Silverman, EK; Tal-Singer, R; Vestbo, J; Wouters, E; Yates, JC | 1 |
Burgel, PR; Mannino, D | 1 |
Ford, ES; Mannino, DM; Redd, SC | 1 |
Banerjee, D; Honeybourne, D; Khair, OA | 1 |
Gan, WQ; Man, SF; Senthilselvan, A; Sin, DD | 1 |
Gan, WQ; Man, SF; Sin, DD | 1 |
Chazan, R; Karwat, K; Kościuch, J | 1 |
Anandan, CL; Fowkes, FG; Lee, AJ; Lowe, GD; Powell, JT; Rumley, A; Smith, FB; Tzoulaki, I | 1 |
Kim, JH; Kim, MS; Lee, HS; Lee, JM; Nam, BH; Song, SW; Zo, JI | 1 |
Bolaman, AZ; Cakir, A; Cildag, O; Polatli, M; Yenicerioglu, Y; Yenisey, C | 1 |
Groenewegen, KH; Hop, WC; Postma, DS; Schlösser, NJ; Wielders, PL; Wouters, EF | 1 |
Creutzberg, EC; Dentener, MA; Mercken, E; Pennings, HJ; Rijkers, GT; Wouters, EF | 1 |
Klimentova, SV; Sannikova, MV; Vakhrushev, IaM | 1 |
Dahl, M; Lange, P; Nordestgaard, BG; Tybjaerg-Hansen, A; Vestbo, J | 1 |
Bhowmik, A; Harper-Owen, R; Jeffries, DJ; Johnston, SL; Maccallum, P; Meade, TW; Message, S; Moric, I; Sanderson, G; Seemungal, T; Wedzicha, JA | 1 |
12 review(s) available for fibrinogen and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.
Topics: Biomarkers; Fibrinogen; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Symptom Flare Up | 2020 |
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
Topics: Biomarkers; Computational Biology; Disease Susceptibility; Drug Development; Fibrinogen; Humans; Liquid Biopsy; Molecular Diagnostic Techniques; Prognosis; Pulmonary Disease, Chronic Obstructive | 2019 |
Biomarkers in COPD.
Topics: Biomarkers; Fibrinogen; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Uteroglobin | 2014 |
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.
Topics: Animals; Biomarkers; C-Reactive Protein; Chemokines, CC; Fibrinogen; Humans; Lung; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Uteroglobin | 2014 |
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.
Topics: Biomarkers; Drug Discovery; Fibrinogen; Humans; Pharmaceutical Preparations; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive; United States; United States Food and Drug Administration | 2016 |
Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; Desmosine; Elastin; Fibrinogen; Humans; Isodesmosine; Leukocyte Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Uteroglobin | 2016 |
Markers of early disease and prognosis in COPD.
Topics: alpha 1-Antitrypsin Deficiency; Biomarkers; C-Reactive Protein; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Denmark; Early Diagnosis; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Hospitalization; Humans; Kaplan-Meier Estimate; Mannose-Binding Lectin; Odds Ratio; Phenotype; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Registries; Risk Assessment; Risk Factors; Severity of Illness Index | 2009 |
Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Biomarkers; C-Reactive Protein; Cholinergic Antagonists; Drug Therapy, Combination; Fibrinogen; Humans; Inflammation; Interleukin-6; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Receptors, Adrenergic, beta-2; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Tumor Necrosis Factor-alpha; Uteroglobin | 2010 |
[Role of inflammation in the etiopathogenesis of COPD].
Topics: Airway Remodeling; Apoptosis; Chemokines; Cytokines; Fibrinogen; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lymphocyte Subsets; Macrophages; Models, Biological; Neutrophils; Nicotiana; Oxidative Stress; Peptide Hydrolases; Pulmonary Disease, Chronic Obstructive; Smoke | 2010 |
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.
Topics: Biomarkers; Disease Progression; Fibrinogen; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2013 |
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
Topics: Adiponectin; Aging; Airway Remodeling; Biomarkers; C-Reactive Protein; Cachexia; Cardiovascular Diseases; CD40 Ligand; Chemokines, CC; Cytokines; Desmosine; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isodesmosine; Lung Neoplasms; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Osteoprotegerin; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Serum Amyloid A Protein; Severity of Illness Index; Telomere; Uteroglobin | 2013 |
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
Topics: C-Reactive Protein; Cytokines; Fibrinogen; Forced Expiratory Volume; Humans; Inflammation; Leukocytes; Pulmonary Disease, Chronic Obstructive; Vital Capacity | 2004 |
15 trial(s) available for fibrinogen and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Effects of Pulmonary Rehabilitation on Systemic Inflammation and Exercise Capacity in Bronchiectasis: A Randomized Controlled Trial.
Topics: Bronchiectasis; Exercise Tolerance; Fibrinogen; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2022 |
Inflammatory responses to acute exercise during pulmonary rehabilitation in patients with COPD.
Topics: Aged; Biomarkers; C-Reactive Protein; Exercise Therapy; Female; Fibrinogen; Humans; L-Selectin; Lung; Male; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2020 |
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Topics: Aged; Biomarkers; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Combinations; Female; Fibrinogen; Humans; Lung; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Time Factors; Treatment Outcome; Up-Regulation | 2021 |
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Cyclopropanes; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Systemic Inflammatory Response Syndrome | 2018 |
Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
Topics: Aged; Autoantigens; Biomarkers; Cohort Studies; Collagen Type IV; Female; Fibrinogen; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Mortality; Pilot Projects; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive | 2019 |
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
Topics: Administration, Inhalation; Aged; Androstadienes; Benzyl Alcohols; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Chlorobenzenes; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Receptor for Advanced Glycation End Products; Symptom Flare Up; Treatment Outcome; Uteroglobin | 2019 |
The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking | 2013 |
[Effect of Qi Benefiting Blood Activating Method on Plasma Fibrinogen and D-dimer in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease].
Topics: Acute Disease; Drugs, Chinese Herbal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Humans; Plasma; Pulmonary Disease, Chronic Obstructive; Qi | 2015 |
Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drainage; Drug Combinations; Electrocoagulation; Female; Fibrinogen; Humans; Length of Stay; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pneumonectomy; Postoperative Complications; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surgical Stapling; Thrombin; Tissue Adhesives; Treatment Outcome | 2009 |
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Albuterol; Androstadienes; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fibrinogen; Fluticasone-Salmeterol Drug Combination; Humans; Male; Middle Aged; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Pyridines; Sputum | 2012 |
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
Topics: Biomarkers; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Fibrinogen; Humans; Interleukin-6; Interleukin-8; Leukocyte Count; Phenotype; Pulmonary Disease, Chronic Obstructive; Smoking; Spirometry; Surveys and Questionnaires; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2012 |
Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; Tars; Vital Capacity | 2013 |
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
Topics: C-Reactive Protein; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Quantitative Trait Loci; Tumor Necrosis Factor-alpha; Uteroglobin | 2012 |
Increased systemic inflammation is a risk factor for COPD exacerbations.
Topics: Aged; Anti-Inflammatory Agents; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Functional Residual Capacity; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Tumor Necrosis Factors | 2008 |
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Biomarkers; C-Reactive Protein; Cachexia; Carrier Proteins; Cytokines; Double-Blind Method; Female; Fibrinogen; Humans; Infliximab; Intercellular Adhesion Molecule-1; Male; Membrane Glycoproteins; Middle Aged; Peroxidase; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Uteroglobin | 2008 |
65 other study(ies) available for fibrinogen and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease.
Topics: Animals; Cadmium; Fibrinogen; Humans; Lung; Macrophage Activation; Mice; Pulmonary Disease, Chronic Obstructive; Toll-Like Receptor 4 | 2022 |
Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.
Topics: Biomarkers; Emphysema; Fibrinogen; Humans; Pneumonia; Prognosis; Pulmonary Disease, Chronic Obstructive; Retrospective Studies | 2022 |
A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.
Topics: Cohort Studies; Community-Acquired Infections; Fibrinogen; Hospital Mortality; Humans; Interleukin-6; Pneumonia; Pulmonary Disease, Chronic Obstructive; Retrospective Studies | 2022 |
Assessment of incidence of cerebral vascular diseases and prediction of stroke risk in chronic obstructive pulmonary disease patients using multimodal biomarkers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Case-Control Studies; Cerebrovascular Disorders; Creatinine; Cross-Sectional Studies; Diffusion Tensor Imaging; Female; Fibrinogen; Humans; Incidence; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Stroke; von Willebrand Factor | 2023 |
Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.
Topics: Fibrinogen; Heart Diseases; Humans; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Uteroglobin | 2023 |
Blood biomarkers in chronic obstructive pulmonary disease: is there a life beyond plasma fibrinogen?
Topics: Biomarkers; Eosinophils; Fibrinogen; Humans; Life; Phenotype; Plasma; Pulmonary Disease, Chronic Obstructive | 2019 |
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Topics: Adult; Aged; Area Under Curve; Betacoronavirus; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Thrombin Time | 2020 |
Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
Topics: Aged; Antigens, CD; C-Reactive Protein; CD11b Antigen; Cell Adhesion Molecules; Cohort Studies; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; GPI-Linked Proteins; Humans; Inflammation; L-Selectin; Leukocyte Count; Male; Middle Aged; Neutrophil Activation; Neutrophils; Physical Therapy Modalities; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Vital Capacity; Walk Test | 2020 |
Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
Topics: Aged; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Biomarkers; C-Reactive Protein; Dyspnea; Eosinophilia; Eosinophils; Female; Fibrinogen; Forced Expiratory Volume; Humans; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Platelet Count; Pulmonary Disease, Chronic Obstructive; Vital Capacity | 2020 |
Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Creatinine; Cytokines; Female; Fibrinogen; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Leukocyte Count; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Quality of Life; Severity of Illness Index; Uric Acid | 2020 |
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Echocardiography; Female; Fibrinogen; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Serbia; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Predictors of Heparin Resistance Before Cardiovascular Operations in Adults.
Topics: Aged; Anticoagulants; Antithrombin III; Aortic Dissection; Cardiopulmonary Bypass; Case-Control Studies; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking | 2018 |
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
Topics: Aged; Aorta; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Muscle Contraction; Muscle Weakness; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Vascular Stiffness | 2018 |
Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease.
Topics: Aged; Biomarkers; Calcifediol; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Phenotype; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Severity of Illness Index | 2019 |
Vitamin D and Chronic Obstructive Pulmonary Disease: Biomarker Related to Outcomes.
Topics: Biomarkers; Fibrinogen; Humans; Phenotype; Pulmonary Disease, Chronic Obstructive; Vitamin D; Vitamin D Deficiency | 2019 |
Frequency of multi-dimensional COPD indices and relation with disease activity markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Health Status; Humans; Male; Middle Aged; Motor Activity; Nitrates; Nitrites; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Albumin; Severity of Illness Index; Spirometry; Surveys and Questionnaires | 2013 |
The COPD Biomarker Qualification Consortium (CBQC).
Topics: Biomarkers; C-Reactive Protein; Desmosine; Disease Progression; Exercise Test; Fibrinogen; Health Status; Humans; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Radiography; Respiratory Function Tests; Respiratory Mechanics; Severity of Illness Index; Sputum; Surveys and Questionnaires; Treatment Outcome; Uteroglobin | 2013 |
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Forced Expiratory Volume; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Odds Ratio; Patient Admission; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Assessment; Severity of Illness Index; Vital Capacity | 2013 |
Systemic inflammation in predicting COPD exacerbations.
Topics: C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Pulmonary Disease, Chronic Obstructive | 2013 |
Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aged; Blood Cell Count; Blood Gas Analysis; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Fibrinogen; Humans; Male; Mean Platelet Volume; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2013 |
Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Cytokines; Erythrocyte Indices; Female; Ferritins; Fibrinogen; Hematocrit; Hemoglobins; Humans; Inflammation; Iron; Male; Middle Aged; Prevalence; Prognosis; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spain; Transferrin | 2013 |
Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Aorta; Blood Pressure; C-Reactive Protein; Cardiomyopathies; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrinogen; Heart Rate; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Risk Factors; Spirometry; Sputum; Troponin T; Vascular Stiffness | 2013 |
Physical activity impairment in depressed COPD subjects.
Topics: Accelerometry; Aged; Anaerobic Threshold; C-Reactive Protein; Depression; Dyspnea; Electric Impedance; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Motor Activity; Nutritional Status; Obesity; Psychiatric Status Rating Scales; Pulmonary Disease, Chronic Obstructive; Quality of Life | 2014 |
Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients.
Topics: Aged; Air Movements; Air Pollutants; Air Pollution; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Forced Expiratory Volume; Hepatocyte Growth Factor; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Nitrogen Dioxide; Obesity; Particulate Matter; Pulmonary Disease, Chronic Obstructive; Research Design; Smoking; Tumor Necrosis Factor-alpha | 2014 |
Evaluating the role of inflammation in chronic airways disease: the ERICA study.
Topics: Adult; Aged; Cardiovascular Diseases; Carotid Intima-Media Thickness; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Muscular Diseases; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Respiratory Muscles; Smoking | 2014 |
Cognitive impairment in chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Attention; Blood Sedimentation; C-Reactive Protein; Cognition; Cognitive Dysfunction; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires | 2014 |
Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers.
Topics: Adiposity; Adult; Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Internationality; Longitudinal Studies; Male; Middle Aged; Prevalence; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Reproducibility of Results; Respiratory Muscles; Sensitivity and Specificity; Sex Characteristics; Sex Distribution; Subcutaneous Fat; Tomography, X-Ray Computed | 2014 |
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Topics: Aged; Area Under Curve; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Disease Progression; Drug Monitoring; Female; Fibrinogen; Humans; Inflammation Mediators; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Receptors, Urokinase Plasminogen Activator; Retrospective Studies; ROC Curve; Time Factors; Treatment Outcome; Up-Regulation | 2015 |
Inflammatory markers and mortality among US adults with obstructive lung function.
Topics: Adult; Age Factors; Aged; Albuminuria; Biomarkers; C-Reactive Protein; Creatinine; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spirometry; United States | 2015 |
Fibrinogen and α1-antitrypsin in COPD exacerbations.
Topics: Aged; Alleles; alpha 1-Antitrypsin; Female; Fibrinogen; Forced Expiratory Volume; Genetic Testing; Genotype; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Retrospective Studies | 2015 |
Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Topics: Aminopyridines; Animals; Benzamides; Blood Platelets; Cardiovascular Diseases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Extracellular Traps; Fibrinogen; Humans; Leukocytes; Macrophage-1 Antigen; Mice; Microscopy, Confocal; Monocytes; Neutrophils; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Phosphorylation; Platelet Adhesiveness; Pulmonary Disease, Chronic Obstructive; Risk; Thromboplastin; Thrombosis | 2016 |
Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Chemokines, CC; Cohort Studies; Depression; Depressive Disorder; Disease Progression; Dyspnea; Exercise Test; Fatigue; Female; Fibrinogen; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Sex Factors; Stroke; Uteroglobin | 2016 |
Precision Medicine in Chronic Obstructive Pulmonary Disease.
Topics: Drug Discovery; Fibrinogen; Humans; Public-Private Sector Partnerships; Pulmonary Disease, Chronic Obstructive | 2016 |
Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Topics: Adult; Aged; Asthma, Occupational; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Occupational Diseases; Occupational Exposure; Pulmonary Disease, Chronic Obstructive; Smoking; Sputum; Tumor Necrosis Factor-alpha | 2016 |
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Biomarkers; Bronchodilator Agents; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Fibrinogen; Forced Expiratory Volume; Humans; Muscarinic Antagonists; Phenotype; Precision Medicine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Severity of Illness Index | 2016 |
Inflammatory markers and longitudinal lung function decline in the elderly.
Topics: Aged; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Geriatric Assessment; Humans; Logistic Models; Longitudinal Studies; Lung Volume Measurements; Male; Multicenter Studies as Topic; Pulmonary Disease, Chronic Obstructive; Spirometry | 2008 |
Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
Topics: Adult; Aged; Biomarkers; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Forced Expiratory Volume; Humans; Interleukin-6; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Ultrasonography; Vasodilation | 2008 |
Clinical, functional and biochemical changes during recovery from COPD exacerbations.
Topics: Aged; Biomarkers; C-Reactive Protein; Disease Progression; Dyspnea; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Interleukin-6; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Severity of Illness Index; Time Factors; Tumor Necrosis Factors; Vital Capacity | 2009 |
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.
Topics: Adult; Aged; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Genome-Wide Association Study; Genotype; Haplotypes; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive | 2009 |
Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men.
Topics: Aged; Aging; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Respiration Disorders; Vascular Cell Adhesion Molecule-1 | 2009 |
The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.
Topics: Aged; Biomarkers; Bronchitis; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Pulmonary Disease, Chronic Obstructive; Regression Analysis | 2009 |
Surgical management of secondary spontaneous pneumothorax in elderly patients with chronic obstructive pulmonary disease: retrospective study of 107 cases.
Topics: Aged; Aged, 80 and over; Evidence-Based Medicine; Female; Fibrinogen; Hospital Mortality; Humans; Injections; Logistic Models; Male; Middle Aged; Patient Selection; Pleurodesis; Pneumothorax; Pulmonary Disease, Chronic Obstructive; Reoperation; Retrospective Studies; Risk Assessment; Risk Factors; Thoracic Surgery, Video-Assisted; Thoracotomy; Time Factors; Treatment Outcome | 2009 |
Documentation of impaired coronary blood flow in chronic obstructive pulmonary disease patients.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Coronary Circulation; Coronary Vessels; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2010 |
Cardiovascular disease and chronic obstructive pulmonary disease.
Topics: Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Circulation; Coronary Vessels; Fibrinogen; Forced Expiratory Volume; Humans; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2010 |
The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway.
Topics: Aged; Bronchoalveolar Lavage Fluid; Female; Fibrinogen; Gene Knockdown Techniques; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages, Alveolar; Male; Middle Aged; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Thromboplastin | 2010 |
Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Female; Fibrinogen; Hospitalization; Humans; Inflammation Mediators; Linear Models; Logistic Models; Lung; Male; Middle Aged; Odds Ratio; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Severity of Illness Index; Spirometry; Time Factors; United States; Up-Regulation | 2012 |
Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Nutrition Surveys; Prognosis; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; United States | 2012 |
Aα-Val360: a marker of neutrophil elastase and COPD disease activity.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Humans; Leukocyte Elastase; Male; Middle Aged; Peptide Fragments; Pulmonary Disease, Chronic Obstructive | 2013 |
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sputum | 2012 |
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity.
Topics: Acute-Phase Proteins; Aged; Biomarkers; Cohort Studies; Comorbidity; Female; Fibrinogen; Forced Expiratory Volume; Granulocyte Colony-Stimulating Factor; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-3; Lipocalin-2; Lipocalins; Male; Metabolic Syndrome; Multivariate Analysis; Proto-Oncogene Proteins; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recombinant Fusion Proteins; Regression Analysis; S100 Proteins; S100A12 Protein; Smoking; Transforming Growth Factor alpha | 2012 |
Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
Topics: Adipokines; Biomarkers; Body Mass Index; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sex Factors | 2012 |
Restless legs syndrome, sleep impairment, and fatigue in chronic obstructive pulmonary disease.
Topics: Age Factors; Aged; Comorbidity; Creatinine; Cross-Sectional Studies; Depression; Fatigue; Ferritins; Fibrinogen; Hemoglobins; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulmonary Disease, Chronic Obstructive; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Statistics, Nonparametric | 2012 |
Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2012 |
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Forced Expiratory Volume; Heart Failure; Humans; Inflammation Mediators; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pneumonia; Pulmonary Disease, Chronic Obstructive; Risk; Vital Capacity | 2012 |
Systemic inflammation in patients with chronic obstructive pulmonary disease: one size no longer fits all!
Topics: C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Pulmonary Disease, Chronic Obstructive | 2012 |
Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Nutrition Surveys; Pulmonary Disease, Chronic Obstructive; Risk Factors; Severity of Illness Index; Smoking; Spirometry; Surveys and Questionnaires; United States | 2003 |
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD.
Topics: Aged; Bacteria; Blood Viscosity; Bronchi; Fibrinogen; Health Status; Humans; Inflammation Mediators; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Sputum | 2004 |
The interactions between cigarette smoking and reduced lung function on systemic inflammation.
Topics: Adult; Aged; C-Reactive Protein; Causality; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Forced Expiratory Volume; Health Surveys; Humans; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Count; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Statistics as Topic; Systemic Inflammatory Response Syndrome; United States | 2005 |
[Is microembolism present and is it important element of COPD exacerbation?].
Topics: Aged; Blood Gas Analysis; Case-Control Studies; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Platelet Count; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Risk Factors; Severity of Illness Index; Spirometry; Surveys and Questionnaires | 2005 |
Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
Topics: Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Forced Expiratory Volume; Hemostasis; Humans; Inflammation; Lung; Male; Pulmonary Disease, Chronic Obstructive; Smoking; Spirometry; Surveys and Questionnaires; Ultrasonography; Vital Capacity | 2006 |
Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchial Fistula; Bronchial Spasm; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Empyema, Pleural; Female; Fibrinogen; Fistula; Humans; Intraoperative Period; Life Tables; Lung Neoplasms; Male; Middle Aged; Pleural Diseases; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome; Retrospective Studies; Risk; Sex Factors; Smoking; Sputum; Survival Analysis; Survival Rate | 2006 |
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Topics: Aged; Albuminuria; Biomarkers; Blood Gas Analysis; Case-Control Studies; Cross-Sectional Studies; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Smoking; Spirometry; Up-Regulation; von Willebrand Factor | 2008 |
[The clinico-functional characteristics of the pancreas in chronic obstructive pulmonary disease].
Topics: Adult; Aged; Amylases; Blood Glucose; Erythrocyte Count; Erythrocytes; Female; Fibrinogen; Hemoglobins; Humans; Insulin; Lipase; Male; Microcirculation; Middle Aged; Pancreas; Pancreatic Diseases; Prothrombin; Pulmonary Disease, Chronic Obstructive; Ultrasonography | 2007 |
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Body Mass Index; Bronchitis; Chronic Disease; Data Interpretation, Statistical; Denmark; Female; Fibrinogen; Forced Expiratory Volume; Hospitalization; Humans; Linear Models; Lung; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk; Risk Factors; Smoking | 2001 |
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
Topics: Aged; Common Cold; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; London; Male; Medical Records; Polymerase Chain Reaction; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Mechanics; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Risk; Statistics, Nonparametric; Virus Diseases | 2001 |